Literature DB >> 16208129

Interaction of haemodynamic and metabolic pathways in the genesis of diabetic nephropathy.

Carlos A Leon1, Leopoldo Raij.   

Abstract

Clinical diabetic nephropathy is characterized by an earlier functional phase in which hyperglycaemia is accompanied by an increased glomerular filtration rate and microalbuminuria; the persistence of this high-flow and high-pressure state, added to a poor control of hyperglycaemia, fosters renal damage and proteinuria, accompanied by a decline in glomerular filtration rate and progression to end-stage renal disease. In this review, we present glucose transporter 1 (GLUT-1) as a novel link that connects the glomerular hyperfiltration (hypertension) state and the complex cascade of events that leads to nephropathy. The interplay between angiotensin II and nitric oxide, and its interactions with reactive oxygen species, are also discussed, in an attempt to provide an integrated view of the pathophysiology of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16208129     DOI: 10.1097/01.hjh.0000188415.65040.5d

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  14 in total

1.  Renal injury in angiotensin II+L-NAME-induced hypertensive rats is independent of elevated blood pressure.

Authors:  Aaron J Polichnowski; Limin Lu; Allen W Cowley
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-26

2.  Roux-en-Y Esophagojejunostomy Ameliorates Renal Function Through Reduction of Renal Inflammatory and Fibrotic Markers in Diabetic Nephropathy.

Authors:  Cuifang Wang; Bing He; Dongxu Piao; Ping Han
Journal:  Obes Surg       Date:  2016-07       Impact factor: 4.129

Review 3.  Obesity, metabolic syndrome and diabetic nephropathy.

Authors:  Christine Maric; John E Hall
Journal:  Contrib Nephrol       Date:  2011-06-09       Impact factor: 1.580

4.  Correlation between SNP genotypes and periodontitis in Japanese type II diabetic patients: a preliminary study.

Authors:  Teerasak Damrongrungruang; Hiroshi Ogawa; Sayaka Hori-Matsumoto; Kumiko Minagawa; Osamu Hanyu; Hirohito Sone; Hideo Miyazaki
Journal:  Odontology       Date:  2014-08-14       Impact factor: 2.634

Review 5.  Obesity and diabetic kidney disease.

Authors:  Christine Maric-Bilkan
Journal:  Med Clin North Am       Date:  2012-11-27       Impact factor: 5.456

Review 6.  Biotransformation effect of Bombyx Mori L. may play an important role in treating diabetic nephropathy.

Authors:  Lei Zhang; Yin Li; Xin-Feng Guo; Xu-Sheng Liu
Journal:  Chin J Integr Med       Date:  2015-12-19       Impact factor: 1.978

7.  Evaluation of renal hypoxia in diabetic mice by BOLD MRI.

Authors:  Pottumarthi Prasad; Lu-Ping Li; Sarah Halter; Joann Cabray; Minghao Ye; Daniel Batlle
Journal:  Invest Radiol       Date:  2010-12       Impact factor: 6.016

Review 8.  Role of angiotensin II in the development of nephropathy and podocytopathy of diabetes.

Authors:  Kirk N Campbell; Leopoldo Raij; Peter Mundel
Journal:  Curr Diabetes Rev       Date:  2011-01

9.  Angiotensin mediates renal fibrosis in the nephropathy of glycogen storage disease type Ia.

Authors:  W H Yiu; C-J Pan; R A Ruef; W-T Peng; M F Starost; B C Mansfield; J Y Chou
Journal:  Kidney Int       Date:  2007-12-12       Impact factor: 10.612

Review 10.  Renal outcomes of bariatric surgery in obese adults with diabetic kidney disease.

Authors:  Bhavana B Rao; Abhik Bhattacharya; Varun Agrawal
Journal:  J Nephrol       Date:  2014-03-19       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.